Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9275208PMCID PMC23274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Essential roles of the Fas ligand in the development of hepatitis

  1997cited by this paper
• Innate Immune Mechanisms Dominate Elimination of Adenoviral Vectors Following In Vivo Administration

  1997cited by this paper
• Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression.

  1997cited by this paper
• Characterization of tumor necrosis factor-deficient mice.

  1997cited by this paper
• Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferon

  1997cited by this paper
• Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes

  1996cited by this paper
• Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response

  1996cited by this paper
• Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.

  1996cited by this paper
• Circumventing the immune response to adenovirus-mediated gene therapy.

  1996cited by this paper
• Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice

  1996cited by this paper
• Use of Transient CD4 Lymphocyte Depletion to Prolong Transgene Expression of E1-Deleted Adenoviral Vectors

  1996cited by this paper
• Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection.

  1996cited by this paper
• Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration.

  1996cited by this paper
• Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis.

  1996cited by this paper
• The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid

  1996cited by this paper
• Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis.

  1996cited by this paper
• The tumor necrosis factor ligand and receptor families.

  1996cited by this paper
• Immunosuppression with monoclonal antibodies and CTLA4-Ig after myoblast transplantation in mice.

  1996cited by this paper
• Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity.

  1996cited by this paper
• Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

  1996cited by this paper
• Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

  1995cited by this paper
• Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo.

  1995cited by this paper
• Long–term hepatic adenovirus–mediated gene expression in mice following CTLA4Ig administration

  1995cited by this paper
• The adenovirus E3 10.4K and 14.5K proteins, which function to prevent cytolysis by tumor necrosis factor and to down-regulate the epidermal growth factor receptor, are localized in the plasma membrane

  1995cited by this paper
• Immunomodulation to enhance gene therapy

  1995cited by this paper
• The Fas death factor

  1995cited by this paper
• The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses

  1995cited by this paper
• Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage

  1995cited by this paper
• Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.

  1995cited by this paper
• Th1 CD4+ lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway.

  1995cited by this paper
• MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

  1994cited by this paper
• Cytokines in the generation of immune responses to, and resolution of, virus infection.

  1994cited by this paper
• Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

  1994cited by this paper
• Adenovirus proteins that subvert host defenses.

  1994cited by this paper
• Immune function in mice lacking the perforin gene.

  1994cited by this paper
• Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity.

  1994cited by this paper
• The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer.

  1994cited by this paper
• Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules.

  1994cited by this paper
• Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy.

  1994cited by this paper
• Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes.

  1994cited by this paper
• Lethal effect of the anti-Fas antibody in mice

  1993cited by this paper
• Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C

  1993cited by this paper
• Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo.

  1993cited by this paper
• Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism

  1993cited by this paper
• Assessment of Recombinant Adenoviral Vectors for Hepatic Gene Therapy

  1993cited by this paper
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

  1992cited by this paper
• Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice

  1992cited by this paper
• The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha

  1992cited by this paper
• The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells

  1991cited by this paper
• Adhesion receptors of the immune system

  1990cited by this paper
• A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse

  1990cited by this paper
• Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons.

  1986cited by this paper
• The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium.

  1985cited by this paper

• Adenovirus E1B-55K interferes with cellular IκB kinase complex subunit proteins

  2025cites this paper
• CRISPR/Cas9-induced knockout of tumor necrosis factor-alpha-type I augments viral infection in zebrafish.

  2024cites this paper
• Tumor necrosis factor‐α polymorphism and risk of primary nephrotic syndrome: A case–control study and meta‐analysis

  2024cites this paper
• Engineering chitosan nano-cocktail containing iron oxide and ceria: A two-in-one approach for treatment of inflammatory diseases and tracking of material delivery.

  2021cites this paper
• Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses

  2017cites this paper
• Chapter 1: Introduction

  2016cites this paper
• Unabated Adenovirus Replication following Activation of the cGAS/STING-Dependent Antiviral Response in Human Cells

  2014cites this paper
• Peptide-Based Technologies to Alter Adenoviral Vector Tropism: Ways and Means for Systemic Treatment of Cancer

  2014cites this paper
• Selective Replicating Viral Vectors

  2012cites this paper
• Tetradecylthioacetic acid modulates cardiac transcription in Atlantic salmon, Salmo salar L., suffering heart and skeletal muscle inflammation.

  2012cites this paper
• Improvements in Gene Therapy

  2012cites this paper
• Japonicone A antagonizes the activity of TNF-α by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1.

  2012cites this paper
• Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin.

  2011cites this paper
• Persistence and the state of bovine and porcine adenoviral vector genomes in human and nonhuman cell lines.

  2011cites this paper
• Adenoviral vector immunity: its implications and circumvention strategies.

  2011cites this paper
• A recombinant myeloid-binding adenovirus for targeted pulmonary gene therapy

  2011cites this paper
• Approaches for improving the safety and efficacy of adenoviral gene therapy

  2010cites this paper
• Type I interferon: a new player in TNF signaling.

  2010cites this paper
• Targeted gene delivery to selected liver segments via isolated hepatic perfusion.

  2010cites this paper
• Maturation-Dependent Licensing of Naive T Cells for Rapid TNF Production

  2010cites this paper
• THE FUNCTION OF INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE 2 IN TOLL-LIKE RECEPTOR-MEDIATED SIGNALING

  2010cites this paper
• Regulation of Early T Cell Activation by TNF Superfamily Members TNF and FASL: A Dissertation

  2010cites this paper
• Adenovirus Induction of IRF3 Occurs through a Binary Trigger Targeting Jun N-Terminal Kinase and TBK1 Kinase Cascades and Type I Interferon Autocrine Signaling

  2009cites this paper
• Infectious pulmonary complications in patients treated with anti-TNF-α monoclonal antibodies and soluble TNF receptor

  2009cites this paper
• Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction.

  2009cites this paper
• Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model.

  2009cites this paper
• A20 Attenuates Allergic Airway Inflammation in Mice1

  2009cites this paper
• Étude de l'autoimmunité contre le foie induite par mimétisme moléculaire

  2008cites this paper
• Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications.

  2008cites this paper
• Incorporation of Membrane-Anchored Flagellin into Influenza Virus-Like Particles Enhances the Breadth of Immune Responses

  2008cites this paper
• TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon–response genes

  2008cites this paper
• The impact of treatment with tumour necrosis factor‐α antagonists on the course of chronic viral infections: a review of the literature

  2008cites this paper
• Adenovirus-Mediated Kallistatin Gene Transfer Ameliorates Disease Progression in a Rat Model of Osteoarthritis Induced by Anterior Cruciate Ligament Transection

  2008cites this paper
• Gene Therapy Protocols

  2008influential citation
• Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis

  2007cites this paper
• Respective roles of TNF-α and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice

  2007cites this paper
• A phase I trial of intravenous infusion of ONYX-015 and enbrel in solid tumor patients

  2007cites this paper
• One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications.

  2007cites this paper
• Blockade of TNF-alpha decreases both inflammation and efficacy of intrapulmonary Ad.IFNbeta immunotherapy in an orthotopic model of bronchogenic lung cancer.

  2006cites this paper
• Current strategies and future directions for eluding adenoviral vector immunity.

  2006cites this paper
• Quantitative analysis of adenoviral vector modification of a cytokine-mediated cell death decision

  2006cites this paper
• Adenoviral vector saturates Akt pro-survival signaling and blocks insulin-mediated rescue of tumor-necrosis-factor-induced apoptosis

  2006cites this paper
• In Vivo Analysis of Adenovirus-Specific Cytotoxic T Lymphocyte Response in Mice Deficient in CD28, Fas Ligand, and Perforin

  2006cites this paper
• NK cell‐mediated immunopathology during an acute viral infection of the CNS

  2006cites this paper
• Modulation of TNFα, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors

  2006cites this paper
• IFN-gamma: a cytokine essential for rejection of CTL-resistant, virus-infected cells.

  2005cites this paper
• The induction of inflammation by adenovirus vectors used for gene therapy.

  2005cites this paper
• IFN-γ: A Cytokine Essential for Rejection of CTL-Resistant, Virus-Infected Cells

  2005cites this paper
• Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus

  2005cites this paper
• Approaches to improving the kinetics of adenovirus-delivered genes and gene products.

  2005cites this paper
• Rapid production of TNF-alpha following TCR engagement of naive CD8 T cells.

  2005cites this paper
• Fas and TNFR1, but not cytolytic granule‐dependent mechanisms, mediate clearance of murine liver adenoviral infection

  2005cites this paper
• Adenoviral delivery of the beta2-adrenoceptor gene in sepsis: a subcutaneous approach in rat for kidney protection.

  2005cites this paper
• Oncolytic viral therapy for human cancer: Challenges revisited

  2005influential citation
• Functions of KSHV-encoded FLIP

  2004cites this paper
• TRAIL and viral infection.

  2004cites this paper
• Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway.

  2004cites this paper
• Oncolytic viral therapies

  2004cites this paper
• An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint

  2004cites this paper
• Defective Clearance of Adenovirus in IRF‐1–/– Mice Associated with Defects in NK and T Cells but not Macrophages

  2004cites this paper
• Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expression.

  2004cites this paper
• Immunobiology of an alphavirus infection in mice

  2004cites this paper
• Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expression

  2004cites this paper
• Immune responses against adenoviral vectors and their transgene products: a review of strategies for evasion.

  2004cites this paper
• The Innate Immune Response to Adenovirus Vectors

  2004cites this paper
• Endocrine aspects of cancer gene therapy.

  2004cites this paper
• Antiviral Cytokines Induce Hepatic Expression of the Granzyme B Inhibitors, Proteinase Inhibitor 9 and Serine Proteinase Inhibitor 61

  2004cites this paper
• The role of TNF–TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection

  2003cites this paper
• Adenovirus encoding soluble tumor necrosis factor alpha receptor immunoglobulin prolongs gene expression of a cotransfected reporter gene in rat lung.

  2003cites this paper
• Selective replicating viral vectors : potential for use in cancer gene therapy.

  2003cites this paper
• Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients

  2003cites this paper
• Rapid in vivo isolation of gene expression elements using an HSV amplicon system.

  2003cites this paper
• Technology evaluation: TNFerade, GenVec.

  2003cites this paper
• CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts

  2003cites this paper
• Lymphocyte-mediated cytotoxicity.

  2003cites this paper
• Adenoviral Infection Decreases Mortality from Lipopolysaccharide-Induced Liver Failure Via Induction of TNF-α Tolerance 1

  2003cites this paper
• Lack of Tumor Necrosis Factor Alpha Induces Impaired Proliferation of Hepatitis B Virus-Specific Cytotoxic T Lymphocytes

  2003cites this paper
• Segregation of Mechanisms for Cytotoxic T Lymphocyte Killing between Lungs and Regional Lymph Nodes Subsequent to Intratracheal Delivery of Adenovirus 2 Vector

  2003cites this paper
• Gene therapy in transplantation.

  2002cites this paper
• Induction of TNF in Human Alveolar Macrophages As a Potential Evasion Mechanism of Virulent Mycobacterium tuberculosis1

  2002cites this paper
• Antiinflammatory effect of retrovirally transfected interleukin-10 on monosodium urate monohydrate crystal-induced acute inflammation in murine air pouches.

  2002cites this paper
• Inhibition of Chemokine Expression by Adenovirus Early Region Three (E3) Genes

  2002cites this paper
• Adenovirus E3-6.7K Maintains Calcium Homeostasis and Prevents Apoptosis and Arachidonic Acid Release

  2002cites this paper
• Selectively replicating viral vectors

  2002cites this paper
• Hepatic DR5 Induces Apoptosis and Limits Adenovirus Gene Therapy Product Expression in the Liver

  2002cites this paper
• Constitutive Expression of the Adenovirus E3-14.7K Protein Does Not Prolong Adenovirus Vector DNA Persistence but Protects Mice Against Lipopolysaccharide-Induced Acute Hepatitis

  2002cites this paper
• Lethal Toxicity, Severe Endothelial Injury, and a Threshold Effect with High Doses of an Adenoviral Vector in Baboons

  2002cites this paper
• Inhibition of Tumor Necrosis Factor Alpha-Induced NF-κB Activation by the Adenovirus E3-10.4/14.5K Complex

  2002cites this paper
• Adenovirus infection induces microglial activation: involvement of mitogen-activated protein kinase pathways.

  2002cites this paper
• Prolongation of transgene expression by coexpression of cytokine response modifier a in rodent liver after adenoviral gene transfer.

  2002cites this paper
• Acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer.

  2002cites this paper
• Improvements in gene therapy: averting the immune response to adenoviral vectors.

  2002cites this paper
• TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection

  2001cites this paper
• Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages.

  2001cites this paper
• Inclusion of the E3 Region in an Adenoviral Vector Decreases Inflammation and Neointima Formation After Arterial Gene Transfer

  2001cites this paper
• Mechanisms Perforin-Dependent CTL Effector Virally Infected Hepatocytes Are Resistant to

  2001influential citation
• TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.

  2001cites this paper
• Expression of TNF-α by Herpes Simplex Virus-Infected Macrophages Is Regulated by a Dual Mechanism: Transcriptional Regulation by NF-κB and Activating Transcription Factor 2/Jun and Translational Regulation Through the AU-Rich Region of the 3′ Untranslated Region1

  2001cites this paper
• Adenoviral Delivery of Human and Viral IL-10 in Murine Sepsis1

  2001cites this paper
• Adenoviral vector-mediated gene transfer for human gene therapy.

  2001cites this paper